ID   YN-1
AC   CVCL_8775
DR   BTO; BTO_0004624
DR   TKG; TKG 0695
DR   Wikidata; Q54995455
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3476772;
RX   PubMed=7918028;
RX   PubMed=8558913;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Doubling time: 20-24 hours (PubMed=7918028).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=7918028; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0695
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 9,10
ST   D7S820: 12
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=3476772; DOI=10.11406/rinketsu.28.667;
RA   Endo K., Tamahashi N.;
RT   "Ultrastructural features of a human erythroid cell line (YN-1).";
RL   Rinsho Ketsueki 28:667-677(1987).
//
RX   PubMed=7918028; DOI=10.1111/j.1365-2141.1993.tb03205.x;
RA   Endo K., Harigae H., Nagai T., Fujie H., Meguro K., Watanabe N.,
RA   Furuyama K., Kameoka J., Okuda M., Hayashi N., Yamamoto M., Abe K.;
RT   "Two chronic myelogenous leukaemia cell lines which represent
RT   different stages of erythroid differentiation.";
RL   Br. J. Haematol. 85:653-662(1993).
//
RX   PubMed=8558913;
RA   Morita S., Tsuchiya S., Fujie H., Itano M., Ohashi Y., Minegishi M.,
RA   Imaizumi M., Endo M., Takano N., Konno T.;
RT   "Cell surface c-kit receptors in human leukemia cell lines and
RT   pediatric leukemia: selective preservation of c-kit expression on
RT   megakaryoblastic cell lines during adaptation to in vitro culture.";
RL   Leukemia 10:102-105(1996).
//
RX   PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4;
RA   Drexler H.G., MacLeod R.A.F., Uphoff C.C.;
RT   "Leukemia cell lines: in vitro models for the study of Philadelphia
RT   chromosome-positive leukemia.";
RL   Leuk. Res. 23:207-215(1999).
//